Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review) by N. A. Shnayder, V. V. Grechkina, V. V. Arkhipov, R. F. Nasyrova

Get full text

Pharmacogenetics-Informed Pharmacometabolomics as an Innovative Approach to Assessing the Safety and Risk of Pharmacotherapy with Valproic Acid by N. A. Shnayder, V. V. Grechkina, V. V. Arkhipov, R. F. Nasyrova

Get full text

Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosis by N. A. Shnayder, V. V. Grechkina, M. Y. Kissin, R. F. Nasyrova

Get full text

Role of neuropeptide Y in development of valproate-induced eating behaviour disorder by N. A. Shnayder, V. V. Grechkina, M. Ya. Kissin, D. V. Dmitrenko, R. F. Nasyrova

Get full text

Selective serotonin reuptake inhibitors in pediatric neurology: a safety issue (systematic review) by N. A. Shnayder, E. A. Makarov, A. V. Kidyaeva, V. V. Grechkina, M. M. Petrova, R. F. Nasyrova

Get full text

The role of microRNAs as regulators of systemic inflammatory response in anticonvulsant-induced metabolic syndrome by N. A. Shnayder, N. A. Pekarets, N. I. Pekarets, Yu. N. Bykov, V. V. Grechkina, D. V. Dmitrenko, M. M. Petrova, R. F. Nasyrova

Get full text